Clinical Trials Browser

Phase 2 × Breast Neoplasms × Irinotecan × Clear all

NCT01042379 2026-03-13

I-SPY

Phase 2 Recruiting

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

NCT00248287 2025-01-29

CA225200

Phase 2 Active not recruiting

154 enrolled 12 charts

Breast Neoplasms

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT02030678 2018-09-05

A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Recurrence

NCT03562390 2018-06-19

Irinotecan for Advanced and Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00617539 2018-04-20

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

Phase 2 Completed

30 enrolled 10 charts

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT00303992 2018-01-17

Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00079118 2016-12-13

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00275041 2016-12-13

Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00003351 2016-07-14

Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00693719 2015-11-20

Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

Phase 2 Completed

31 enrolled 8 charts

Breast Neoplasms

NCT00004182 2012-06-06

Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00072852 2008-10-16

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

Phase 2 Completed

Breast Neoplasms